Skip to main content

Table 3 Inter-rater agreement

From: Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool

  Inter-rater agreement (%)
  Overall Part 1 Part 2 Part 3
1st pilot round (n = 5) 87.1 92.2 76.9
2nd pilot round (n = 4) NA NA 77.5
3rd round (n = 29) NA NA 86.4
  1. n, number of orphan medicinal products under review; NA, not applicable.